Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review

Sarah Denniston1, F Andrew I Riordan

  • 1Department of Paediatrics, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B4 5SS, United Kingdom.

The Journal of Infection
|February 16, 2006
PubMed

Insights

Staphylococcus aureus bacteraemia (SAB) in children and neonates presents differently than in adults, with lower mortality and MRSA rates. Hospital-acquired SAB is less common in pediatrics, making it an unreliable performance indicator.

Area of Science:

  • Medical Microbiology
  • Pediatric Infectious Diseases
  • Hospital Epidemiology

Background:

  • Staphylococcus aureus bacteraemia (SAB) is a key indicator of hospital-acquired infections in adults, often linked to central venous catheters (CVCs) and high mortality.
  • Limited data exists on SAB in pediatric and neonatal populations within the UK.

Purpose of the Study:

  • To characterize the presentation, management, and outcomes of SAB in a UK District General Hospital's neonatal and pediatric units over a decade.

Main Methods:

  • Retrospective review of case notes for children under 16 with SAB between May 1993 and April 2003.
  • Defined hospital-acquired SAB as occurring >48 hours post-admission.
  • Identified contaminants based on clinical presentation, repeat cultures, and treatment.

Main Results:

  • Neonatal Unit: 33 episodes reviewed; 9% contaminants, all hospital-acquired. 87% had non-specific presentations, 57% had CVCs. 27% had MRSA, 10% mortality.
  • Pediatric Unit: 64 episodes reviewed; 20% contaminants, 20% hospital-acquired. Common presentations included skin and bone/joint infections. Only 2 MRSA cases, 2% mortality.

Conclusions:

  • SAB in neonates resembles adult patterns, while pediatric SAB differs significantly.
  • Children and neonates experience lower mortality and MRSA incidence compared to adults.
  • Pediatric SAB has a weaker association with CVCs and a lower hospital-acquired rate, questioning its utility as a performance indicator.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...